ARTICLE | Clinical News
Anagrelide CR: Additional Phase II data
June 15, 2015 7:00 AM UTC
Additional data from an open-label, U.S. Phase II trial in 18 patients with elevated platelet counts secondary to essential thrombocythemia and other myeloproliferative neoplasms showed that twice-dai...